Matches in Wikidata for { <http://www.wikidata.org/entity/Q89568764> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q89568764 description "2018 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q89568764 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q89568764 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89568764 description "scientific article published on 11 July 2018" @default.
- Q89568764 description "wetenschappelijk artikel" @default.
- Q89568764 description "наукова стаття, опублікована в липні 2018" @default.
- Q89568764 name "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 name "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 type Item @default.
- Q89568764 label "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 label "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 prefLabel "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 prefLabel "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 P1104 Q89568764-8B1A5815-F466-4B57-A2EE-FCC31F0E042B @default.
- Q89568764 P1433 Q89568764-99DD4747-8C10-4F3C-8232-3B4E342E1E16 @default.
- Q89568764 P1476 Q89568764-B20B6EA7-4577-4419-A293-C0A994B8B6BE @default.
- Q89568764 P2093 Q89568764-06A73EFF-490E-472C-9ADF-51EA408BAE01 @default.
- Q89568764 P2093 Q89568764-3E436A07-ECFF-4C38-AA9C-D553094ABFBC @default.
- Q89568764 P2093 Q89568764-8C0A39CE-003D-4256-8B5B-ED8953CB9B1C @default.
- Q89568764 P2093 Q89568764-B6823605-B8B0-4437-8AEB-E9242B435843 @default.
- Q89568764 P2093 Q89568764-BCDBEC80-A8C2-4372-86DB-068F0D27EDC2 @default.
- Q89568764 P2093 Q89568764-E1715F49-97A6-4833-AB12-507F2CECB090 @default.
- Q89568764 P304 Q89568764-FA7695D5-90A1-4069-BF3A-F7EF2DCE14AB @default.
- Q89568764 P31 Q89568764-69BD53AE-78F9-4C0F-A6D5-258E2147FED5 @default.
- Q89568764 P356 Q89568764-69CF6830-B053-4942-B62A-06FD2B887C21 @default.
- Q89568764 P433 Q89568764-2BD44758-CB47-43F1-8296-FCD82BC25654 @default.
- Q89568764 P478 Q89568764-099F58FD-BD05-4F2D-B3DB-80388F844279 @default.
- Q89568764 P577 Q89568764-DFF6157F-EFFC-485E-A76E-104AEA12661B @default.
- Q89568764 P698 Q89568764-028FBBB5-FEA7-4815-8B87-8536C6C1F69B @default.
- Q89568764 P921 Q89568764-5E5A6429-8097-43EF-9585-663D159E1DC2 @default.
- Q89568764 P921 Q89568764-DEF926D0-1C1A-471B-B284-EE1205B2B0CF @default.
- Q89568764 P921 Q89568764-F930584F-7BAD-4DDD-8F5A-3CC49615DB42 @default.
- Q89568764 P356 000489345 @default.
- Q89568764 P698 29996128 @default.
- Q89568764 P1104 "+7" @default.
- Q89568764 P1433 Q15759092 @default.
- Q89568764 P1476 "Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks" @default.
- Q89568764 P2093 "Catalina Navarro-Palop" @default.
- Q89568764 P2093 "Cecilia Chiarri-Toumit" @default.
- Q89568764 P2093 "Enrique Cervera-Taulet" @default.
- Q89568764 P2093 "Javier Montero-Hernández" @default.
- Q89568764 P2093 "Laura Hernández-Bel" @default.
- Q89568764 P2093 "Verónica Castro-Navarro" @default.
- Q89568764 P304 "98-104" @default.
- Q89568764 P31 Q13442814 @default.
- Q89568764 P356 "10.1159/000489345" @default.
- Q89568764 P433 "2" @default.
- Q89568764 P478 "241" @default.
- Q89568764 P577 "2018-07-11T00:00:00Z" @default.
- Q89568764 P698 "29996128" @default.
- Q89568764 P921 Q18558081 @default.
- Q89568764 P921 Q422252 @default.
- Q89568764 P921 Q4689286 @default.